All the risk is transferred to SSL due to consolidation in API business which is risky day by day due to USFDA strictness. STAR shareholders own 60% of SSL. No new innovative molecule is announced, only re juggling of business which looks good initially, we will know after 2 years when everything
2.29 PM Mar 28th
The company has clarified on the exchanges that Tesaro has got approval from FDA and NOT DISHMAN pharma. Since the company does not manufacture the innovator`s end product in CRAMS segment, it is Tesaro lnc., which has received the US FDA approval for cancer drug Zejula Capsules and not Dishman
2.07 PM Mar 28th
Through LTTS focus on automotive technologies, the center will propel the regional economy into the next phase of growth, delivering quality services, expanding workforce, and supporting major projects in the region through innovative engineering processes.
4.44 PM Mar 27th
and the short cut they adopted was to throttle the production so that the price of crude increases. the scheme was good, but they got greedy and stretched the crude price to just $55-57 just below the break even cost of shale gas. people with shale gas inventory, were not sitting idle, they innovated
1.07 PM Mar 27th